4. Li F, Svarovsky MJ, Karlsso AJ, et al. Eap1p, an adhesin that mediates Candida albicans biofilm formation in vitro and in vivo. Eucaryot Cell. 2007;6:931-9.10.1128/EC.00049-07195151917416898
8. Karkowska-Kuleta J, Rapala-Kozik M, Kozik A. Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Acta Biochem Pol. 2009;56(2):211-24.10.18388/abp.2009_2452
10. De Sordi L, Muhlschlegel F. Quorum sensing and fungal – bacterial interactions in Candida albicans: a communicative network regulating microbial coexistence and virulence. Yeast Res. 2009;9(7): 990-9.10.1111/j.1567-1364.2009.00573.x19845041
11. Uppuluri P, Chaturvedi AK, Lopez-Ribot J. Design of simple model of Candida albicans biofilm formed under conditions of flow: development, architecture and drug resistance. Mycopathologia 2009;168(3):101-9.10.1007/s11046-009-9205-9397275319370400
13. Chandra J, Kuhn DM, Mukherjee PK, et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183:5385-94.10.1128/JB.183.18.5385-5394.20019542311514524
14. Ten Cate JM, Klis FM, Pereira-Cenci T, Crielaard W. Molecular and cellular mechanisms lead to Candida biofilm formation. J Dent. Res. 2009;88(2):105-15.10.1177/0022034508329273
15. Ene IV, Bennett RJ. Hwp1 and related adhesins contribute to both miting and biofilm formation in Candida albicans. Eukaryot Cell. 2009;12:1909-13.10.1128/EC.00245-09